Terms: = Endocrine gland cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
16 results:
1. Expression and clinical value of cxcr4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
2. Usefulness of 68 Ga-Pentixafor PET/CT on diagnosis and Management of Cushing Syndrome.
Ding J; Tong A; Hacker M; Feng M; Huo L; Li X
Clin Nucl Med; 2022 Aug; 47(8):669-676. PubMed ID: 35452014
[TBL] [Abstract] [Full Text] [Related]
3. Specific Receptors for the Chemokines CXCR2 and cxcr4 in Pancreatic cancer.
Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Kędra B; Mroczko B
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867211
[TBL] [Abstract] [Full Text] [Related]
4. Autologous Stem-Cell Transplantation Outcomes for Relapsed Metastatic Germ-Cell Tumors in the Modern Era.
Hamid AA; Markt SC; Vicier C; McDermott K; Richardson P; Ho VT; Sweeney CJ
Clin Genitourin Cancer; 2019 Feb; 17(1):58-64.e1. PubMed ID: 30309761
[TBL] [Abstract] [Full Text] [Related]
5. Targeting cxcr4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
Heinze B; Fuss CT; Mulatero P; Beuschlein F; Reincke M; Mustafa M; Schirbel A; Deutschbein T; Williams TA; Rhayem Y; Quinkler M; Rayes N; Monticone S; Wild V; Gomez-Sanchez CE; Reis AC; Petersenn S; Wester HJ; Kropf S; Fassnacht M; Lang K; Herrmann K; Buck AK; Bluemel C; Hahner S
Hypertension; 2018 Feb; 71(2):317-325. PubMed ID: 29279316
[TBL] [Abstract] [Full Text] [Related]
6. cxcr4/Let-7a Axis Regulates Metastasis and Chemoresistance of Pancreatic cancer Cells Through Targeting HMGA2.
Xiao G; Wang X; Yu Y
Cell Physiol Biochem; 2017; 43(2):840-851. PubMed ID: 28954272
[TBL] [Abstract] [Full Text] [Related]
7. Protocol of the PANCALYZE trial: a multicenter, prospective study investigating the tumor biomarkers cxcr4, SMAD4, SOX9 and IFIT3 in patients with resected pancreatic adenocarcinoma to predict the pattern of recurrence of the disease.
Popp FC; Popp MC; Zhao Y; Betzler C; Kropf S; Garlipp B; Benckert C; Kalinski T; Lippert H; Bruns CJ
BMC Cancer; 2017 Mar; 17(1):229. PubMed ID: 28356064
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear receptors in pancreatic tumor cells.
Damaskos C; Garmpis N; Karatzas T; Kostakis ID; Nikolidakis L; Kostakis A; Kouraklis G
Anticancer Res; 2014 Dec; 34(12):6897-911. PubMed ID: 25503115
[TBL] [Abstract] [Full Text] [Related]
10. CD40 signal regulates cxcr4 mediating ovarian carcinoma cell migration: implications for extrapelvic metastastic factors.
Qu QX; Huang Q; Xu J; Duan LT; Zhu YB; Zhang XG
Oncol Res; 2013; 20(9):383-92. PubMed ID: 23924922
[TBL] [Abstract] [Full Text] [Related]
11. diagnosis of postoperative pancreatic fistula.
Facy O; Chalumeau C; Poussier M; Binquet C; Rat P; Ortega-Deballon P
Br J Surg; 2012 Aug; 99(8):1072-5. PubMed ID: 22539219
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
13. Conditionally replicating adenovirus expressing TIMP2 for ovarian cancer therapy.
Yang SW; Cody JJ; Rivera AA; Waehler R; Wang M; Kimball KJ; Alvarez RA; Siegal GP; Douglas JT; Ponnazhagan S
Clin Cancer Res; 2011 Feb; 17(3):538-49. PubMed ID: 21115652
[TBL] [Abstract] [Full Text] [Related]
14. The molecular mechanisms of traditional Chinese medicine ZHENG syndromes on pancreatic tumor growth.
Dai HY; Wang P; Feng LY; Liu LM; Meng ZQ; Zhu XY; Wang K; Hua YQ; Mao YX; Chen LY; Chen Z
Integr Cancer Ther; 2010 Sep; 9(3):291-7. PubMed ID: 20702498
[TBL] [Abstract] [Full Text] [Related]
15. CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1.
Torregrossa L; Faviana P; Filice ME; Materazzi G; Miccoli P; Vitti P; Fontanini G; Melillo RM; Santoro M; Basolo F
Thyroid; 2010 May; 20(5):495-504. PubMed ID: 20450430
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Luo M; Zhan S; Xie K; Ma Y; Li QQ
Int J Biol Markers; 2010; 25(1):38-45. PubMed ID: 20306451
[TBL] [Abstract] [Full Text] [Related]
